| National Blood Authority | National Fractionation Agreement | A$3.4B | 2018-01-10 |
| National Blood Authority | National Supply arrangement for imported immunoglobulin products | A$1.9B | 2026-06-09 |
| National Blood Authority | Supply of imported immunoglobulin products | A$568.8M | 2023-04-27 |
| National Blood Authority | Imported Plasma and Recombinant Products | A$271.3M | 2026-07-03 |
| National Blood Authority | Supply of Imported Plasma and Recombinant Products (IPRP) | A$190.5M | 2023-04-27 |
| National Blood Authority | Procurement of Imported Plasma and Recombinant Products (IPRP) - Idelvion | A$73.6M | 2025-07-18 |
| National Blood Authority | Imported Plasma and Recombinant Products (Factor XI Concentrate) | A$8.3M | 2026-07-16 |
| National Blood Authority | Supply of Imported Plasma and Recombinant Products | A$6.5M | 2023-04-27 |